✦ LIBER ✦

Bortezomib therapy alone and in combination with dexamethasone for previously untreated symptomatic multiple myeloma

✍ Scribed by Sundar Jagannath; Brian G. M. Durie; Jeffrey Wolf; Elber Camacho; David Irwin; Jose Lutzky; Marti McKinley; Eli Gabayan; Amitabha Mazumder; David Schenkein; John Crowley

Book ID: 108673228
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 125 KB
Volume: 129
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2005.05540.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PAD combination therapy (PS-341/bortezom

PAD combination therapy (PS-341/bortezomib, doxorubicin and dexamethasone) for previously untreated patients with multiple myeloma

✍ Heather E. Oakervee; Rakesh Popat; Nicola Curry; Pat Smith; Curly Morris; Mary D 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

Thalidomide in combination with vincrist

Thalidomide in combination with vincristine, epirubicin and dexamethasone (VED) for previously untreated patients with multiple myeloma

✍ P. Schütt; P. Ebeling; U. Buttkereit; D. Brandhorst; B. Opalka; M. Hoiczyk; M 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB

Bortezomib, thalidomide, and dexamethaso

Bortezomib, thalidomide, and dexamethasone as induction therapy for patients with symptomatic multiple myeloma : A retrospective study

✍ Jonathan L. Kaufman; Ajay Nooka; Mark Vrana; Charise Gleason; L. Thompson Heffne 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

## Abstract ## BACKGROUND: This single‐center retrospective study determined the efficacy of bortezomib, thalidomide, and dexamethasone (BTD) as induction for patients with multiple myeloma (MM) who were eligible for autologous stem cell transplantation (ASCT). ## METHODS: Patients with symptoma

Bortezomib in combination with dexametha

Bortezomib in combination with dexamethasone for a young multiple myeloma with t(8; 14)

✍ Jian-yong Li; Li-xia Wang; Wen-yi Shen; Shi-feng Lu; Li-juan Chen; Hua Lu 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 141 KB

VTD combination therapy with bortezomib–

VTD combination therapy with bortezomib–thalidomide–dexamethasone is highly effective in advanced and refractory multiple myeloma

✍ Pineda-Roman, M; Zangari, M; van Rhee, F; Anaissie, E; Szymonifka, J; Hoering, A 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 279 KB

Retreatment with bortezomib alone or in

Retreatment with bortezomib alone or in combination for patients with multiple myeloma following an initial response to bortezomib

✍ Raman Sood; Harry Carloss; Robert Kerr; Jose Lopez; Martin Lee; Mark Druck; Ian 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views